Cell mediated and humoral immune responses in oral submucous fibrosis

Cell‐mediated and humoral immune responses were assessed in 50 patients with oral submucous fibrosis (OSMF) and the results were compared with those of 50 patients with oral‐leukoplakia, 50 oral cancer patients, and 50 normal healthy adult controls. The number of high‐affinity rosette‐forming cells...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1986-12, Vol.58 (12), p.2628-2631
Main Authors: Rajendran, R., Sugathan, C. K., Remani, P., Ankathil, Ravindran, Vijayakumar, T.
Format: Article
Language:English
Subjects:
Adult
Antibody Formation
Antibody-Producing Cells - immunology
Biological and medical sciences
Dermatology
Female
Humans
Immunity, Cellular
Immunoglobulins - analysis
Leukoplakia - immunology
Male
Medical sciences
Middle Aged
Mouth Diseases - immunology
Mouth Neoplasms - immunology
Oral Submucous Fibrosis - immunology
Rosette Formation
Tumors of the skin and soft tissue. Premalignant lesions
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell‐mediated and humoral immune responses were assessed in 50 patients with oral submucous fibrosis (OSMF) and the results were compared with those of 50 patients with oral‐leukoplakia, 50 oral cancer patients, and 50 normal healthy adult controls. The number of high‐affinity rosette‐forming cells (HARFC) was found to be significantly decreased in OSMF and oral cancer, whereas the number of total rosette‐forming cells (TRFC) remained unaltered. Levels of serum IgA, IgD, and IgE were found to be elevated both in OSMF and oral cancer. Immunologic derangements were found to be more pronounced in oral cancer than in OSMF. The enumeration of HARFC along with the estimation of serum levels of IgA, IgD, and IgE indicates that OSMF can be an intermediary stage in the malignant transformation of a normal cell, and that these parameters may serve as markers for the early detection of oral cancer.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(19861215)58:12<2628::AID-CNCR2820581214>3.0.CO;2-Z